
c-Met/HGFR
c-Met/HGFR inhibitors target the Hepatocyte Growth Factor Receptor (c-Met), a tyrosine kinase involved in cellular processes such as growth, motility, and morphogenesis. c-Met signaling is implicated in cancer progression, metastasis, and resistance to therapies. Inhibiting c-Met can disrupt tumor growth and spread, making these inhibitors valuable in cancer research. At CymitQuimica, we offer c-Met/HGFR inhibitors to support your research in oncology, metastasis, and targeted cancer therapies.
Found 148 products for "c-Met/HGFR".
Filter by
Purity percentage
0
100
|
0
|
50
|
90
|
95
|
100
- Lower prices
- Higher prices
- Lower purities
- Higher purities
- Faster estimated delivery
Dalmelitinib
CAS:Dalmelitinib: oral c-Met kinase inhibitor, IC50 2.9 nM, disrupts MET, AKT, ERK in cancer cells, for NSCLC research.Formula:C22H16FN7O2SColor and Shape:SolidMolecular weight:461.47LCRF-0004
CAS:LCRF-0004 inhibits RON kinase, key in KRAS-driven pancreatic cancer, reducing cell migration and enhancing chemo sensitivity.Formula:C28H18F4N6O2SColor and Shape:SolidMolecular weight:578.54Mifanertinib dimaleate
CAS:Mifanertinib dimaleate is a potent tyrosine kinase inhibitor with antineoplastic activity .Formula:C29H27ClF3N5O10Color and Shape:SolidMolecular weight:698(R)-Afatinib
CAS:(R)-Afatinib: oral ErbB inhibitor (EGFR/HER2), IC50 ≤14 nM. For ESCC, NSCLC, gastric cancer research.Formula:C24H25ClFN5O3Color and Shape:SolidMolecular weight:485.94MK-8033 hydrochloride
CAS:MK-8033 hydrochloride is an oral ATP-competitive c-Met/Ron inhibitor (IC50: c-Met 1nM, Ron 7nM), used for various cancers including NSCLC.Formula:C25H22ClN5O3SColor and Shape:SolidMolecular weight:507.992Mifanertinib
CAS:Mifanertinib is a potent tyrosine kinase inhibitor with antineoplastic activity .Formula:C21H19ClF3N5O2Color and Shape:SolidMolecular weight:465.86Glesatinib hydrochloride
CAS:Glesatinib hydrochloride is an orally active and potent dual inhibitor of MET/SMO.Formula:C31H28ClF2N5O3S2Purity:98%Color and Shape:SolidMolecular weight:656.166SAR125844
CAS:SAR125844, a potent and highly selective inhibitor of the MET receptor tyrosine kinase (RTK), for intravenous administration. (IC50 value of 4.2 nmol/L)Formula:C25H23FN8O2S2Purity:98.73%Color and Shape:White SolidMolecular weight:550.631AC-386
CAS:AC-386, a potent c-Met inhibitor (IC50 7.42 nM), inhibits cancer cell growth and aids anti-cancer resistance study.Formula:C35H34FN5O6Color and Shape:SolidMolecular weight:639.67c-Met-IN-16
CAS:c-Met-IN-16 is a c-Met inhibitor that can be used for cancer research .Formula:C21H17F2N9OColor and Shape:SolidMolecular weight:449.42Anti-Human MST1R Antibody (MOR07692)
Anti-MST1R Antibody (MOR07692) is a humanized IgG1 monoclonal antibody specifically targeting MST1R.c-Met-IN-13
CAS:c-Met-IN-13: potent c-Met inhibitor (IC50 2.43 nM), exhibits anti-proliferative, cytotoxic effects; potential cancer therapy.Formula:C30H28F2N2O6Color and Shape:SolidMolecular weight:550.55c-Met-IN-12
CAS:c-Met-IN-12: potent c-Met/AXL/Mer/TYRO3 inhibitor, IC50=10.6 nM, oral, anti-tumor, scaffold for selectivity enhancement.Formula:C34H29FN4O4Color and Shape:SolidMolecular weight:576.62T-1840383
CAS:T-1840383 blocks VEGFR-2 and c-Met phosphorylation in endothelial and cancer cells.Formula:C30H25ClFN5O4Color and Shape:SolidMolecular weight:574CE-355621
CE-355621 is a humanized anti-c-Met IgG1 monoclonal antibody. It effectively binds to human c-Met in A549 cells (KD= 200 pM, IC50= 466 pM) and also binds effectively to c-Met in cynomolgus monkey kidney cells (KD= 610 pM). CE-355621 inhibits the c-Met signaling pathway by blocking HGF binding and significantly suppresses tumor growth dependent on the c-Met/HGF pathway. It is applicable for research in cancers such as glioblastoma and gastric cancer.Color and Shape:Odour LiquidVabametkib
CAS:Vabametkib: potent HGFR inhibitor, IC50 = 7 nM, halts Hs746T cell growth, used in cancer therapy.Formula:C29H34N12OColor and Shape:SolidMolecular weight:566.66Boditrectinib
CAS:Boditrectinib: potent TKI, anti-cancer, researches cancer, inflammation, neurodegeneration, infections.Formula:C23H24F2N6OColor and Shape:SolidMolecular weight:438.47c-Met-IN-11
CAS:c-Met-IN-11 is a potent inhibitor of c-MET (IC50: 41.4 nM) and VEGFR-2 (IC50: 71.1 nM).Formula:C30H20F2N4O3Color and Shape:SolidMolecular weight:522.5Axl-IN-8
CAS:Axl-IN-8 (NO.1) is a potent inhibitor of AXL (IC50<1 nM) and also inhibits c-MET (IC50: 1-10 nM). : 120.3 nM).Formula:C31H29FN6O3Color and Shape:SolidMolecular weight:552.6Terevalefim
CAS:Terevalefim (ANG-3777) is an hepatocyte growth factor (HGF) mimetic. Terevalefim selectively activates the c-Met receptor.Formula:C9H8N2SPurity:99.8%Color and Shape:SolidMolecular weight:176.238

